A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group-Reference-Cited by-同舟云学术

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group

Published:2013-04 Issue:4 Volume:24 Page:1099-1104
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Pautier P.,Floquet A.,Gladieff L.,Bompas E.,Ray-Coquard I.,Piperno-Neumann S.,Selle F.,Guillemet C.,Weber B.,Largillier R.,Bertucci F.,Opinel P.,Duffaud F.,Reynaud-Bougnoux A.,Delcambre C.,Isambert N.,Kerbrat P.,Netter-Pinon G.,Pinto N.,Duvillard P.,Haie-Meder C.,Lhommé C.,Rey A.

Funder

Association pour la Recherche contre le Cancer

Chugaï Pharma

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/4/1099/719522/mds545.pdf

Reference27 articles.

1. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874);Reed;Eur J Cancer,2008

2. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma;Pautier;Cancer,2000